Insider Transactions in Q1 2023 at Treace Medical Concepts, Inc. (TMCI)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
95,000
-9.31%
|
$2,375,000
$25.36 P/Share
|
|
Mar 30
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
50,000
-5.2%
|
$1,250,000
$25.86 P/Share
|
|
Mar 30
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
38,498
-3.64%
|
$1,000,948
$26.0 P/Share
|
|
Mar 29
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
32,457
-2.62%
|
$811,425
$25.28 P/Share
|
|
Mar 28
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
26,241
-2.08%
|
$656,025
$25.02 P/Share
|
|
Mar 23
2023
|
Lawrence W Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
2,753
+35.29%
|
-
|
|
Mar 15
2023
|
Thomas E Timbie Director |
SELL
Open market or private sale
|
Indirect |
50,000
-4.17%
|
$1,150,000
$23.03 P/Share
|
|
Mar 15
2023
|
Daniel E. Owens |
SELL
Open market or private sale
|
Direct |
6,250
-16.82%
|
$137,500
$22.87 P/Share
|
|
Mar 15
2023
|
Daniel E. Owens |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+14.4%
|
$43,750
$7.03 P/Share
|
|
Mar 14
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,400
-0.74%
|
$216,200
$23.25 P/Share
|
|
Mar 13
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,400
-0.37%
|
$225,600
$24.4 P/Share
|
|
Mar 10
2023
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+35.52%
|
-
|
|
Mar 10
2023
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,925
+41.44%
|
-
|
|
Mar 10
2023
|
Daniel E. Owens |
BUY
Grant, award, or other acquisition
|
Direct |
20,625
+40.02%
|
-
|
|
Mar 10
2023
|
Mark Hair Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,825
+38.59%
|
-
|
|
Mar 10
2023
|
Aaron Berutti SVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
29,800
+41.02%
|
-
|
|
Mar 10
2023
|
John T. Treace Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
82,475
+1.45%
|
-
|
|
Mar 09
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
1,502
-0.14%
|
$39,052
$26.0 P/Share
|
|
Mar 09
2023
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
SELL
Open market or private sale
|
Direct |
177
-0.78%
|
$4,248
$24.41 P/Share
|
|
Mar 09
2023
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
505
-5.06%
|
$12,120
$24.41 P/Share
|
|
Mar 09
2023
|
Daniel E. Owens |
SELL
Open market or private sale
|
Direct |
411
-3.84%
|
$9,864
$24.41 P/Share
|
|
Mar 09
2023
|
Mark Hair Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,040
-3.69%
|
$24,960
$24.41 P/Share
|
|
Mar 09
2023
|
Aaron Berutti SVP, Sales |
SELL
Open market or private sale
|
Direct |
733
-5.32%
|
$17,592
$24.41 P/Share
|
|
Mar 09
2023
|
John T. Treace Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,075
-0.04%
|
$49,800
$24.41 P/Share
|
|
Mar 08
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
45,000
-2.06%
|
$1,035,000
$23.25 P/Share
|
|
Mar 01
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
50,000
-4.33%
|
$1,050,000
$21.35 P/Share
|
|
Mar 01
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
12,684
-1.3%
|
$266,364
$21.36 P/Share
|
|
Feb 28
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
37,316
-3.69%
|
$783,636
$21.54 P/Share
|
|
Feb 22
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,400
-0.73%
|
$197,400
$21.97 P/Share
|
|
Feb 21
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
9,400
-0.72%
|
$197,400
$21.74 P/Share
|
|
Feb 16
2023
|
Thomas E Timbie Director |
SELL
Bona fide gift
|
Indirect |
8,300
-2.24%
|
-
|
|
Feb 15
2023
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-71.48%
|
$525,000
$21.69 P/Share
|
|
Feb 15
2023
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+41.68%
|
$0
$0.1 P/Share
|
|
Feb 15
2023
|
Thomas E Timbie Director |
SELL
Open market or private sale
|
Indirect |
50,000
-4.0%
|
$1,050,000
$21.71 P/Share
|
|
Feb 08
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
27,731
-2.09%
|
$582,351
$21.7 P/Share
|
|
Feb 07
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
8,800
-0.66%
|
$202,400
$23.0 P/Share
|
|
Feb 02
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
4,011
-0.35%
|
$96,264
$24.0 P/Share
|
|
Jan 31
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
11,929
-1.17%
|
$274,367
$23.19 P/Share
|
|
Jan 30
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
1,054
-0.1%
|
$25,296
$24.55 P/Share
|
|
Jan 30
2023
|
James T Treace |
SELL
Open market or private sale
|
Direct |
37,017
-1.76%
|
$851,391
$23.34 P/Share
|
|
Jan 30
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
90,989
-2.47%
|
$2,092,747
$23.79 P/Share
|
|
Jan 25
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
27,722
-1.02%
|
$693,050
$25.51 P/Share
|
|
Jan 24
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
25,921
-1.86%
|
$673,946
$26.03 P/Share
|
|
Jan 18
2023
|
Thomas E Timbie Director |
SELL
Open market or private sale
|
Indirect |
50,000
-3.85%
|
$1,250,000
$25.88 P/Share
|
|
Jan 17
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
11,014
-0.87%
|
$286,364
$26.0 P/Share
|
|
Jan 13
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
6,519
-0.51%
|
$169,494
$26.0 P/Share
|
|
Jan 12
2023
|
F Barry Bays |
SELL
Open market or private sale
|
Direct |
45,536
-1.6%
|
$1,138,400
$25.54 P/Share
|
|
Jan 12
2023
|
Richard W Mott |
SELL
Open market or private sale
|
Direct |
42,467
-3.24%
|
$1,104,142
$26.0 P/Share
|
|
Jan 12
2023
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-71.48%
|
$625,000
$25.57 P/Share
|
|
Jan 12
2023
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+41.68%
|
$0
$0.1 P/Share
|